Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Change in Receivables (2020 - 2025)

Biofrontera has reported Change in Receivables over the past 6 years, most recently at $4.3 million for Q4 2025.

  • Quarterly results put Change in Receivables at $4.3 million for Q4 2025, up 768.29% from a year ago — trailing twelve months through Dec 2025 was $1.9 million (up 505.4% YoY), and the annual figure for FY2025 was $1.9 million, up 505.4%.
  • Change in Receivables for Q4 2025 was $4.3 million at Biofrontera, up from -$947000.0 in the prior quarter.
  • Over the last five years, Change in Receivables for BFRIW hit a ceiling of $4.3 million in Q4 2025 and a floor of -$3.1 million in Q2 2022.
  • Median Change in Receivables over the past 5 years was $149500.0 (2021), compared with a mean of $222000.0.
  • Biggest five-year swings in Change in Receivables: crashed 30900.0% in 2022 and later surged 768.29% in 2025.
  • Biofrontera's Change in Receivables stood at $1.8 million in 2021, then increased by 19.7% to $2.2 million in 2022, then plummeted by 38.93% to $1.3 million in 2023, then crashed by 63.06% to $492000.0 in 2024, then soared by 768.29% to $4.3 million in 2025.
  • The last three reported values for Change in Receivables were $4.3 million (Q4 2025), -$947000.0 (Q3 2025), and -$88000.0 (Q2 2025) per Business Quant data.